相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel insights into the function and dynamics of extracellular matrix in liver fibrosis
Morten A. Karsdal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Challenges and Opportunities in Drug and Biomarker Development for Nonalcoholic Steatohepatitis: Findings and Recommendations From an American Association for the Study of Liver Diseases-US Food and Drug Administration Joint Workshop
Arun J. Sanyal et al.
HEPATOLOGY (2015)
COL6A3 Expression in Adipocytes Associates with Insulin Resistance and Depends on PPARγ and Adipocyte Size
Simon N. Dankel et al.
OBESITY (2014)
Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction
Kai Sun et al.
NATURE COMMUNICATIONS (2014)
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
D. J. Leeming et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
Inhibition of endotrophin, a cleavage product of collagen VI, confers cisplatin sensitivity to tumours
Jiyoung Park et al.
EMBO MOLECULAR MEDICINE (2013)
Endotrophin in the tumor stroma: a new therapeutic target for breast cancer?
Jiyoung Park et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Relationship between adipose tissue insulin resistance and liver histology in nonalcoholic steatohepatitis: A pioglitazone versus vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis trial follow-up study
Lauren N. Bell et al.
HEPATOLOGY (2012)
Adipocyte-derived endotrophin promotes malignant tumor progression
Jiyoung Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
R. Agrawal et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
A novel oral form of salmon calcitonin improves glucose homeostasis and reduces body weight in diet-induced obese rats
M. Feigh et al.
DIABETES OBESITY & METABOLISM (2011)
Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy
Kim Henriksen et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
MMP Mediated Degradation of Type VI Collagen Is Highly Associated with Liver Fibrosis - Identification and Validation of a Novel Biochemical Marker Assay
Sanne Skovgard Veidal et al.
PLOS ONE (2011)
Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)
Bernard Charbonnel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Adipose Tissue Collagen VI in Obesity
Magdalena Pasarica et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
Tayeba Khan et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
Ian J. Douglas et al.
PLOS MEDICINE (2009)
Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress
Nobuo Cho et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
New Drugs for Type 2 Diabetes Mellitus What is their Place in Therapy?
Andrew J. Krentz et al.
DRUGS (2008)
Dissociation of antihyperglycaemic and adverse effects of partial perioxisome proliferator-activated receptor (PPAR-γ) agonist balaglitazone
Philip J. Larsen et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance
A. K. Lampe et al.
HUMAN MUTATION (2008)
The effect of thiazolidinediones on BMD and osteoporosis
Allyson K. McDonough et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Pioglitazone use and heart failure in patients with type 2 diabetes and preexisting cardiovascular disease: data from the PROactive study (PROactive 08)
Erland Erdmann et al.
DIABETES CARE (2007)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Long-term risk of cardiovascular events with rosiglitazone - A meta-analysis
Sonal Singh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Thiazolidinedi ones and their fluid-related adverse effects - Facts, fiction and putative management strategies
Janaka Karalliedde et al.
DRUG SAFETY (2007)
The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
Giorgio Bedogni et al.
BMC GASTROENTEROLOGY (2006)
The C5 domain of the collagen VI α3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells
Shireen R. Lamande et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alpha
Dariusz Marek Lebensztejn et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Serum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B
DM Lebensztejn et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
PPARs: therapeutic targets for metabolic disease
JP Berger et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Collagen VI related muscle disorders
AK Lampe et al.
JOURNAL OF MEDICAL GENETICS (2005)
Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis
MA Sorocéanu et al.
JOURNAL OF ENDOCRINOLOGY (2004)
The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion
T Aigner et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Serum collagen type VI and XIV and hyaluronic acid as early indicators for altered connective tissue turnover in alcoholic liver disease
F Stickel et al.
DIGESTIVE DISEASES AND SCIENCES (2001)
分享论文
